News Markets Research

News

Headlines Threads Atlas

© 2026 Araverus

About Contact Privacy Terms

Araverus does not provide financial, investment, or trading advice. All content is for informational purposes only. Full disclaimer

News
/
Tech
/
Biotech

Eli Lilly strengthens genetic medicine pipeline, acquiring Orna Therapeutics for $2.4 billion

Story Thread|Global M&A Activity Surges Across Diverse Sectors

Araverus Team|Monday, February 9, 2026 at 6:19 PM

Araverus Team

Feb 9, 2026 · 6:19 PM

Biotech Acquisition · Eli Lilly · Genetic Medicine · Orna Therapeutics

Biotech Acquisition Eli Lilly Genetic Medicine Orna Therapeutics

Eli Lilly has announced its acquisition of Orna Therapeutics for up to $2.4 billion, aiming to enhance its capabilities in genetic medicine and in-vivo cell engineering.

Thread Timeline: Global M&A Activity Surges Across Diverse Sectors

Show 25 older articles...

Mar 19, 20263M, Bain Capital Acquire Madison, Form Safety JV

Mar 19, 2026Ecolab Nears $5 Billion CoolIt Systems Acquisition

Mar 20, 2026Smiths Group Sells Detection for £2 Billion, Boosts Shareholder Returns

Mar 20, 2026Prestige Buys Breathe Right, Boosts Portfolio

Mar 23, 2026Poste Italiane Bids $12.5 Billion for Telecom Italia

Mar 23, 2026Berkshire Hathaway Invests $1.8B in Tokio Marine Stake

Mar 23, 2026Danone Acquires Huel for €1 Billion, Boosts Nutrition

Mar 23, 2026Grab Acquires Foodpanda Taiwan for $600 Million

Mar 23, 2026OnlyFans Owner Radvinsky Dies; Billion-Dollar Sale at Risk

Mar 23, 2026Gilead Acquires Ouro, Partners Galapagos for Autoimmune Drug

Mar 24, 2026Estée Lauder, Puig Discuss Merger Amid Industry Slowdown

Mar 24, 2026Estée Lauder, Puig Discuss Potential Cosmetics Merger

Mar 24, 2026Apollo Funds Acquire Nippon Sheet Glass for $3.7 Billion

Mar 24, 2026SMFG Explores Jefferies Takeover; Shares Climb

Mar 24, 2026Trian, General Catalyst Finalize Janus Henderson Acquisition at $52

Mar 25, 2026Diageo Subsidiary Sells IPL Franchise for £1.33 Billion

Mar 25, 2026UniFirst Shares Soar on Cintas' $5.5 Billion Acquisition

Mar 25, 2026KKR Acquires Nothing Bundt Cakes for Over $2 Billion

Mar 25, 2026ADW Capital Urges Driven Brands to Explore Sale

Mar 26, 2026Vinci Highways Acquires Nine Indian Toll Roads

Mar 26, 2026Henkel Acquires Olaplex for $1.4 Billion, Exiting Advent

Mar 26, 2026

ECP Acquires BG Group's New England Gas Plants for $450M

Mar 26, 2026Corebridge, Equitable Merge: $22 Billion Retirement Giant Forms

Mar 26, 2026Pernod Ricard Eyes Brown-Forman Deal; Shares Rise

Mar 27, 2026BASF Sells Harbour Energy Stake, Upsized Placing

Mar 27, 2026Pernod Ricard Eyes Brown-Forman Deal, Shares Rally

Mar 27, 2026Two Harbors Bidding War Escalates; Shares Surge

Mar 27, 2026Advent Acquires Automic Group, Targets Global Expansion

Mar 28, 2026Trump Media Merges Fusion Firm TAE Technologies

Mar 29, 2026McCormick Bids for Unilever Food Division

Read More On

Eli Lilly to Buy Biotech Orna Therapeutics for Up to $2.4 Billionwsj.com

Eli Lilly to Buy Biotech Orna Therapeutics for Up to $2.4 Billion - marketscreener.commarketscreener.com

Eli Lilly to Buy Biotech Orna Therapeutics for Up to $2.4 Billion -- Update - MarketScreener Indiain.marketscreener.com

Eli Lilly to Acquire Orna Therapeutics in $2.4 Billion Deal - marketscreener.commarketscreener.com

Eli Lilly to Acquire Orna Therapeutics in $2.4 Billion Deal - Startup Researcherstartupresearcher.com

Related Articles

Tech★★Similarity: 72% · 70d ago

Innovent Biologics Strikes Partnership Deal With Eli Lilly

Chinese drugmaker Innovent Biologics and Eli Lilly plan to target cancer and immune system diseases under the partnership.

Markets★★Similarity: 64% · 72d ago

Biogen Revenue Down as Multiple Sclerosis Sales Slide

Biogen swung to a loss as results were hurt by a double-digit decline in revenue from its core multiple sclerosis treatments.

Tech★★Similarity: 63% · 74d ago

Texas Instruments to Acquire Silicon Labs in Deal Valued at $7.5 Billion

Texas Instruments agreed to acquire Silicon Labs in a deal with an enterprise value of about $7.5 billion, including cash and debt.

Markets★★★Similarity: 63% · 66d ago

Asset Manager Nuveen to Buy U.K. Peer Schroders in $13.5 Billion Deal

The deal marks the latest tie-up in the asset-management industry as firms are racing to build the scale needed to weather relentless fee pressure.